VG Life Sciences, Inc. engages as a drug discovery and development company. It focuses on Targeted Peptide Technology (TPT), and Metabolic Disruption Technology (MDT). The TPT deals with HIV/AIDS. The MDT helps to fight cancers with solid tumors in situations where the cancer is resistant to the initial cancer drug therapy. The company was founded by Haig Keledjian in 1994 and is headquartered in San Marino, CA.